UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $2.8M of United Therapeutics Corporation
Sold$2,828,672
$367.36Price
7,700Shares
−17%Stake
What UTHR did after the filing
- The stock from Mon, Nov 25 open, $374.82
- −2.6%
- S&P 500, same days
- −2.8%
Measured over 30 trading days, to the Jan 10 close.
Traded Thu, Nov 21. Filed Fri, Nov 22, 5:37 PM ET, after the close. Returns use the Nov 25 open and the Jan 10 close. Not investment advice.